DK1343508T3 - Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis - Google Patents

Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis

Info

Publication number: DK1343508T3
Authority: DK; Denmark
Prior art keywords: estrogen; manufacture; treatment; composition containing; atrophic vaginitis
Prior art date: 2000-12-15

Application number

DK01270333.6T

Other languages

English (en)

Inventor

Karen Koch

Ingelise Kvorning

Original Assignee

Novo Nordisk Femcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-15

Filing date

2001-12-13

Publication date

2012-02-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1343508(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-13 Application filed by Novo Nordisk Femcare Ag filed Critical Novo Nordisk Femcare Ag

2012-02-27 Application granted granted Critical

2012-02-27 Publication of DK1343508T3 publication Critical patent/DK1343508T3/da

Links

239000000262 estrogen Substances 0.000 title abstract 4
238000004519 manufacturing process Methods 0.000 title abstract 2
229940011871 estrogen Drugs 0.000 title 2
208000004746 Atrophic Vaginitis Diseases 0.000 title 1
206010003693 Atrophic vulvovaginitis Diseases 0.000 title 1
201000010808 postmenopausal atrophic vaginitis Diseases 0.000 title 1
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
229960005309 estradiol Drugs 0.000 abstract 1
229930182833 estradiol Natural products 0.000 abstract 1
230000003442 weekly effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

DK01270333.6T 2000-12-15 2001-12-13 Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis DK1343508T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DKPA200001892		2000-12-15
DKPA200001890		2000-12-15
DKPA200001891		2000-12-15
PCT/DK2001/000824 WO2002047692A1 (en)	2000-12-15	2001-12-13	Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis

Publications (1)

Publication Number	Publication Date
DK1343508T3 true DK1343508T3 (da)	2012-02-27

Family

ID=27222474

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK01270333.6T DK1343508T3 (da)	2000-12-15	2001-12-13	Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis
DK10179223.2T DK2366395T2 (da)	2000-12-15	2001-12-13	Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK10179223.2T DK2366395T2 (da)	2000-12-15	2001-12-13	Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis

Country Status (10)

Country	Link
EP (3)	EP3747443A3 (da)
JP (2)	JP4851057B2 (da)
AT (1)	ATE532521T1 (da)
AU (1)	AU2002221567A1 (da)
CY (1)	CY1112542T1 (da)
DE (2)	DE10179223T1 (da)
DK (2)	DK1343508T3 (da)
ES (2)	ES2725774T1 (da)
PT (1)	PT1343508E (da)
WO (1)	WO2002047692A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3747443A3 (en)	2000-12-15	2021-03-03	Novo Nordisk Health Care AG	Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
GT200500315A (es) *	2004-11-02	2006-06-06		Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
EP3272333A1 (en) *	2016-07-22	2018-01-24	Chemo Research, S.L.	Vaginal composition comprising a combination of estrogen and vitamin d
EP3603626A1 (en)	2018-07-31	2020-02-05	Mucosa Innovations, S.L.	Composition for use in the prevention and/or treatment of the genitourinary mucosa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2739558B1 (fr) *	1995-10-05	1997-11-28	Innothera Lab Sa	Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
AU5181200A (en) *	1999-06-04	2000-12-28	General Hospital Corporation, The	Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
EP3747443A3 (en)	2000-12-15	2021-03-03	Novo Nordisk Health Care AG	Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis

2001
- 2001-12-13 EP EP20193530.1A patent/EP3747443A3/en not_active Withdrawn
- 2001-12-13 DK DK01270333.6T patent/DK1343508T3/da active
- 2001-12-13 ES ES10179223T patent/ES2725774T1/es active Pending
- 2001-12-13 AU AU2002221567A patent/AU2002221567A1/en not_active Abandoned
- 2001-12-13 DE DE10179223.2T patent/DE10179223T1/de active Pending
- 2001-12-13 DK DK10179223.2T patent/DK2366395T2/da unknown
- 2001-12-13 PT PT01270333T patent/PT1343508E/pt unknown
- 2001-12-13 WO PCT/DK2001/000824 patent/WO2002047692A1/en not_active Ceased
- 2001-12-13 EP EP10179223A patent/EP2366395A1/en not_active Ceased
- 2001-12-13 ES ES01270333T patent/ES2376649T3/es not_active Expired - Lifetime
- 2001-12-13 EP EP01270333A patent/EP1343508B1/en not_active Revoked
- 2001-12-13 JP JP2002549263A patent/JP4851057B2/ja not_active Expired - Fee Related
- 2001-12-13 AT AT01270333T patent/ATE532521T1/de active
- 2001-12-14 DE DE20120246U patent/DE20120246U1/de not_active Expired - Lifetime
2010
- 2010-04-08 JP JP2010089241A patent/JP2010189409A/ja active Pending
2012
- 2012-01-18 CY CY20121100064T patent/CY1112542T1/el unknown

Also Published As

Publication number	Publication date
EP1343508A1 (en)	2003-09-17
EP2366395A1 (en)	2011-09-21
EP3747443A3 (en)	2021-03-03
ES2376649T3 (es)	2012-03-15
JP4851057B2 (ja)	2012-01-11
JP2004515531A (ja)	2004-05-27
CY1112542T1 (el)	2015-12-09
EP1343508B1 (en)	2011-11-09
DE10179223T1 (de)	2019-10-24
JP2010189409A (ja)	2010-09-02
EP3747443A2 (en)	2020-12-09
ATE532521T1 (de)	2011-11-15
WO2002047692A1 (en)	2002-06-20
PT1343508E (pt)	2012-02-20
DK2366395T2 (da)	2020-06-15
DK2366395T1 (da)	2019-09-23
DE20120246U1 (de)	2002-05-29
AU2002221567A1 (en)	2002-06-24
ES2725774T1 (es)	2019-09-27

Similar Documents

Publication	Publication Date	Title
EA200201000A1 (ru)	2003-02-27	Гормон-заместительная терапия
DK1446128T3 (da)	2007-04-02	Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
WO2002094275A8 (en)	2003-02-13	Use of estrogen compounds to increase libido in women
ES2174517T3 (es)	2002-11-01	Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
ES2177506T3 (es)	2002-12-16	Extractos de te verde que contienen catecoles y cafeina.
NO20032805L (no)	2003-08-20	Blandinger med ostrogen-syklodekstrinkomplekser
DK1157037T3 (da)	2003-11-24	GCSF-konjugater
EA200600964A1 (ru)	2006-10-27	Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
AU7315301A (en)	2002-01-14	Compounds and compositions for delivering active agents
MXPA02007942A (es)	2004-09-10	Derivados de pirrolopirimidinona, procesos de preparacion y uso.
CY1112542T1 (el)	2015-12-09	Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας
DK1051159T3 (da)	2002-08-05	Faste farmaceutiske præparater indeholdende miltefosin til oral administration ved behandling af leishmaniasis
SG154323A1 (en)	2009-08-28	Estrogen replacement therapy
BG105570A (en)	2002-02-28	Pharmaceutical compositions for modified release insulin sensitiser
MY128392A (en)	2007-01-31	6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
EA200301129A1 (ru)	2004-04-29	Ингибирование ароматазы для улучшения вспомогательной репродукции
AU6538801A (en)	2001-12-17	Methods and compositions using sulodexide for the treatment of diabetic nephropathy
EA200700979A1 (ru)	2007-10-26	Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола
DE60202954D1 (de)	2005-03-17	Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
AR006034A1 (es)	1999-07-21	Una composicion antitranspirante, un sistema antitranspirante que la comprende y la utilizacion de un emoliente en la preparacion de la misma
EP1322315A4 (en)	2004-05-26	FORMULATIONS CONTAINING URSODESOXYCHOLIC ACID FOR REDUCING OR SUPPRESSING TOXICITY OF ENDOCRINE MODULATORS
NZ334411A (en)	2000-09-29	Non-aqueous antiperspirant composition
IL153010A0 (en)	2003-06-24	3,3-dimethylcyclohexane derivatives
ES1010439U (es)	1990-01-01	Dispensador desechable de dosis unica para cremas vaginales y similares.
DK1261345T3 (da)	2005-09-12	Urtetilskud til kognitivt relateret svækkelse som fölge af östrogenmangel